Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation
Children in developing countries are frequently exposed to the pneumococcus, but few develop invasive pneumococcal disease (IPD). We test the hypothesis that natural variation exists in the rapidity of IgG responses following exposure to pneumococcal polysaccharides, and that these differences are s...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Nature Publishing Group
2018
|
| _version_ | 1797061126159073280 |
|---|---|
| author | Kimaro Mlacha, S Warira, A Gatakaa, H Goldblatt, D Scott, J |
| author_facet | Kimaro Mlacha, S Warira, A Gatakaa, H Goldblatt, D Scott, J |
| author_sort | Kimaro Mlacha, S |
| collection | OXFORD |
| description | Children in developing countries are frequently exposed to the pneumococcus, but few develop invasive pneumococcal disease (IPD). We test the hypothesis that natural variation exists in the rapidity of IgG responses following exposure to pneumococcal polysaccharides, and that these differences are sufficiently great to affect susceptibility to and outcome of IPD. We recruited children aged 24-36 months, who had recovered from IPD, and age-matched healthy controls and vaccinated them with 1 dose of the 23-valent PPV to mimic natural exposure. We collected serum samples after vaccination and analysed the dynamics of anti-polysaccharide antibody responses to several capsular antigens. Mean IgG response times to different serotypes were 6.4-7.3 days, with standard deviations of 0.9-1.85 days, suggesting a natural range in response times of up to 7 days. Serotype 1 elicited the largest fold-rise, serotype 23F the smallest. The proportion of responses achieved by day 7 was similar in children with a history of IPD and healthy children. There was considerable natural variation in the rapidity of anti-capsular IgG responses extending over 4-7 days. There was no evidence to suggest that children who have experienced IPD respond more slowly to heterologous pneumococcal capsular antigens than do healthy children. |
| first_indexed | 2024-03-06T20:26:35Z |
| format | Journal article |
| id | oxford-uuid:2f995da0-262a-4edc-a02d-58d08850a4bf |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:26:35Z |
| publishDate | 2018 |
| publisher | Nature Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:2f995da0-262a-4edc-a02d-58d08850a4bf2022-03-26T12:56:20ZOutpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulationJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2f995da0-262a-4edc-a02d-58d08850a4bfEnglishSymplectic Elements at OxfordNature Publishing Group2018Kimaro Mlacha, SWarira, AGatakaa, HGoldblatt, DScott, JChildren in developing countries are frequently exposed to the pneumococcus, but few develop invasive pneumococcal disease (IPD). We test the hypothesis that natural variation exists in the rapidity of IgG responses following exposure to pneumococcal polysaccharides, and that these differences are sufficiently great to affect susceptibility to and outcome of IPD. We recruited children aged 24-36 months, who had recovered from IPD, and age-matched healthy controls and vaccinated them with 1 dose of the 23-valent PPV to mimic natural exposure. We collected serum samples after vaccination and analysed the dynamics of anti-polysaccharide antibody responses to several capsular antigens. Mean IgG response times to different serotypes were 6.4-7.3 days, with standard deviations of 0.9-1.85 days, suggesting a natural range in response times of up to 7 days. Serotype 1 elicited the largest fold-rise, serotype 23F the smallest. The proportion of responses achieved by day 7 was similar in children with a history of IPD and healthy children. There was considerable natural variation in the rapidity of anti-capsular IgG responses extending over 4-7 days. There was no evidence to suggest that children who have experienced IPD respond more slowly to heterologous pneumococcal capsular antigens than do healthy children. |
| spellingShingle | Kimaro Mlacha, S Warira, A Gatakaa, H Goldblatt, D Scott, J Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation |
| title | Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation |
| title_full | Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation |
| title_fullStr | Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation |
| title_full_unstemmed | Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation |
| title_short | Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation |
| title_sort | outpacing the pneumococcus antibody dynamics in the first few days following pneumococcal capsular antigen stimulation |
| work_keys_str_mv | AT kimaromlachas outpacingthepneumococcusantibodydynamicsinthefirstfewdaysfollowingpneumococcalcapsularantigenstimulation AT wariraa outpacingthepneumococcusantibodydynamicsinthefirstfewdaysfollowingpneumococcalcapsularantigenstimulation AT gatakaah outpacingthepneumococcusantibodydynamicsinthefirstfewdaysfollowingpneumococcalcapsularantigenstimulation AT goldblattd outpacingthepneumococcusantibodydynamicsinthefirstfewdaysfollowingpneumococcalcapsularantigenstimulation AT scottj outpacingthepneumococcusantibodydynamicsinthefirstfewdaysfollowingpneumococcalcapsularantigenstimulation |